One of the out-patient treatment alternatives for clients in East Orange battling with opioid abuse and addiction is called opioid maintenance therapy. Some centers and doctors are authorized to administer certain medications to opioid addicted clients, many of which are opioids themselves and are addictive. With low amounts however, the individual doesn't experience high feelings and also doesn't have severe cravings and isn't in opioid withdrawal. Methadone is the first med administered for this sole purpose, but there are other options currently to pick from.
Methadone is an opiate and is meant to be taken at an out-patient medical center certified to dispense the med, which is taken daily as a pill or liquid. The price of the med is about under $200 per month. Buprenorphine is also an opioid-based drug, and is in pill form often taken every other day. But different from Methadone that is only be dispensed in well-regulated medical centers, Buprenorphine can be prescribed and dispensed in doctor's offices. The monthly cost of buprenorphine is approximately $300.00 per month for the generic of the medication. There is also a version of buprenorphine containing the drug naloxone, which is a med that reverses the effects of opiates. Someone consuming this formulation, also known as Suboxone, would find it harder to get high from opioids if they relapsed while taking the drug. It too is taken daily, and costs about $450 per month. Naltrexone is an additional med used in opioid maintenance therapy, but unlike the other drugs aforementioned it's an opioid blocker and is not an opioid. A person has the choice to take this drug as a monthly injection, and that is called Vivitrol. As an opioid blocker, it prevents a person from feeling high from opioids, and therefore lowers the risk associated with relapse. This daily shot costs in the range of $1000 to $1200 a month.
There are 2 Alcohol and Drug Treatment Programs offering this service in East Orange, NJ
For All Alcohol and Drug Rehab Centers In East Orange, Click Here.